Expert Directory
Martin Mahoney, MD
Chair of the Department of Clinical Prevention
Roswell Park Comprehensive Cancer CenterFamily Medicine,Health Behavior,HPV,Lung Cancer,Preventive Medicine,Primary Care,Smoking Cessation,Vaccination
Blood Cancer,Bone Marrow,Bone Marrow Transplant,Cancer,hematologic oncology,Leukemia,Lymphoma,Multiple Myeloma
Carl Morrison, MD
Executive Director of the Center for Personalized
Roswell Park Comprehensive Cancer CenterCancer,Cancer Genetics,Genomics,Medical Diagnostics,Molecular Diagnostics,molecular pathology,Personalized Medicine
Dr. Carl D. Morrison joined the faculty of Roswell Park Comprehensive Cancer Center in January 2007, and is currently the Senior Vice President of Scientific Development and Integrative Medicine; Director of the Pathology Resource Network; Clinical Chief, Department of Pathology & Laboratory Medicine; Director, Division of Molecular Pathology, and Professor of Oncology. Prior to coming to Roswell Park, Dr. Morrison spent five years as faculty at The Ohio State University Medical Center after completing his residency there in Anatomic Pathology. Dr. Morrison is a board-certified pathologist with a Certificate of Qualification in Oncology in NYS who has an interest in both clinical and research areas. As Senior Vice President of Scientific Development and Integrative Medicine, Dr. Morrison supports the development of new core capabilities and technology platforms in order to conduct highly integrative research across both the basic sciences and clinical care. Dr. Morrison continues to lead the Pathology Resource Network (PRN) at Roswell Park. The overall goal of the PRN is to facilitate access to human biospecimens for IRB-approved investigators with an emphasis on translational efforts. The services offered are quite diverse and serve a unique link between the research and clinical arena. Dr. Morrison started and previously directed the Clinical Data Network (CDN) at Roswell Park. The CDN is the organization of clinical data for research purposes utilizing a federated database approach. The primary goal of the CDN is the promotion of translational research at Roswell Park in a non-human subject research setting.
Igor Puzanov, MD
Director of Early Phase Clinical Trials Program an
Roswell Park Comprehensive Cancer CenterCancer,Cancer Vaccines,immunotheraphy,Melanoma,Novel Therapies,Personalized Medicine
His role as a Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Professor of Medicine and Director of Early Phase Clinical Trials Program in the Department of Medicine at Roswell Park Comprehensive Cancer Center, He is developing novel therapies for patients with cancer. This includes clinical trials from the early pre-clinical phase through phase I/II/III with emphasis on a combination of immune and targeted agents, novel drug design, including histology-agnostic trial development of targeted therapies. He also provides advice on regulatory requirements and necessary steps associated with advancing drugs, devices, and imaging agents toward clinical trials in patients. In his professional career, I have focused both on developing precision medicine agents as well as immunotherapies. In the first-in-human trial of PLX4032/vemurafenib, our team has provided critical PK/PD data that led to the first in class/ first in human FDA-approved BRAF inhibitor. His interest and expertise in immunotherapy started in the early 1990s with animal models of IL-2 and IL-15 cytokines and natural killer cell development, continued with high dose IL-2 studies, and subsequently Phase I-III trials with both CTLA-4 and PD1/PDL-1 checkpoint inhibitors. Our team was instrumental in the development of talimogene laherparepvec, the first in human oncolytic virus therapy for patients with melanoma. Recently, we have explored immunotherapy combinations with targeted agents as well as combinations of oncolytic viruses with checkpoint inhibitors. Our work was instrumental in several FDA approvals of breakthrough anti-cancer drugs (vemurafenib, dabrafenib+trametinib, vemurafenib+cobimetinib, pembrolizumab, talimogene laherparepvec) and resulted in almost 100 manuscripts, including New England Journal of Medicine, Lancet, Journal of Clinical Oncology, JAMA, Nature. I am a member of American Society of Medical Oncology, Society of Immunotherapy in Cancer, ACP, AACR and Society of Melanoma Research and serve as an editor and reviewer for several peer reviewed journals.
Cancer,Cancer Detection,Cancer Prevention,Cancer Screening,Epidemiology,Lung Cancer
Counterterrorism,Cybersecurity,Military History,Security,Terrorism
Since 2006, Davis has worked extensively with the military in the homeland security enterprise and force generation. During a twenty-year Army career, Lieutenant Colonel (Ret) Davis served in a variety of command and staff positions in airborne, ranger, and Special Forces units. While an instructor at the US Army Infantry School, 1987-89, he was the principal author for the revision of Field Manual 7-10, The Rifle Company Manual. His military awards include the Bronze Star Medal, Combat Infantryman's Badge, and Master Parachutist Badge. From 1997-2000, Davis served as a training consultant in the US State Department's Train and Equip Program in Bosnia-Herzegovina. From 2000-2005, he worked in public education as a JROTC instructor in San Antonio, Texas. Davis earned two degrees from Texas A&M University: a bachelor's in history (1976) and a PhD in education (2003). At Troy State University, he earned a master's degree in international relations (1989). Author of numerous articles, Dr. Davis most recent book, The Phinehas Priesthood: Violent Vanguard of the Christian Identity Movement, was published by Praeger Publishers in 2010. He and his wife Mary live on the Corner Ranch in South Texas.
Insurgency,political violence,Terrorism,transnational criminal groups
Tom is a Lecturer in International Relations for the University of Portsmouth based at the Royal Air Force College Cranwell. He specializes in terrorism, political violence, and insurgencies with a focus on Southeast Asia but more broadly on jihadist (al Qaeda, ISIS, etc.) and political violence related to transnational Islam. He has fieldwork experience in Mindanao in the Philippines and Southern Thailand and is regularly asked by development, conflict and governmental organizations to contribute to research design, project planning and for advice. A former Visiting Lecturer at De La Salle University in Manila, Tom has worked across Asia in conflict environments for NGOs, charities and IGOs. Tom is best known on an international basis for his expertise on the Abu Sayyaf Group in the Southern Philippine province of Mindanao but has also become perhaps one of the UKs most recognised authorities on Filipino politics and Filipino foreign affairs.
Physiological,Psychological,Survival
He has spent over 30 years researching and advising in the areas of thermoregulation, environmental and occupational physiology and survival in the sea. He has published over 400 scientific papers, reports, chapters and books in these areas. Professor Tipton is a consultant in survival and thermal medicine to the Royal Air Force and UKSport; he sits on the Royal National Lifeboat Institution’s Medical & Survival Committee, Surf Lifesaving GB’s medical and research advisory panel and the Ectodermal Dysplasia Society’s medical advisory board. He Chairs UKSport’s Research Advisory Group which oversees all medical and technological research undertaken with and for Team GB’s athletes. Professor Tipton provides advice to a range of universities, government departments, industries, medical, search and rescue and media organizations.
Citizen Science,Galaxy Evolution,Galaxy Formation,galaxy kinematics and dynamics,Morphology
Research interests: Galaxy formation and evolution. Galaxy kinematics. Galaxy morphologies. Citizen Science (especially in Astronomy). Karen's interests are in the area of extragalactic astronomy. She studies how galaxies formed and evolve in our universe using data from large surveys like the Sloan Digital Sky Survey. She is the Project Scientist for Galaxy Zoo and often uses information on galaxy shapes and types collected from this citizen science project in her research.
Drone,drone operations,Ethics,Military intervention,Politics
Dr Peter Lee is a University of Portsmouth Reader in Politics and Ethics who specializes in the ethical and operational aspects of remotely piloted aircraft (drone) operations, as well as the politics and ethics of war and military intervention. He writes in various formats with a particular focus on the UK’s Royal Air Force Reaper drone squadrons. Between July and December 2016 he was granted unprecedented research access by the Royal Air Force to British Reaper drone operations at both RAF Waddington in Lincolnshire, UK and Creech Air Force Base outside Las Vegas, Nevada. He was able to observe both surveillance and lethal missile strikes against Islamic State jihadists in Syria and Iraq: in real time and in close-up detail. He has also conducted in-depth interviews with 70 members of the Royal Air Force Reaper drone community for his next book, Reaper Force: The Inside Story of Britain’s Drone Wars. Peter is regularly invited to lecture on this and other subjects to military, academic, political, religious, media and wider audiences. From June 2015 to June 2016 he was a member of the Department for Transport Oversight Committee for the Sciencewise public dialogue: The Use and Development of Remotely Piloted Aircraft Systems and Small Drones in the United Kingdom, which preceded the current government consultation on drones. In 2012 he published Blair’s Just War: Iraq and the Illusion of Morality and in 2015 published Truth Wars: The Politics of Climate Change, Military Intervention and Financial Crisis, both with Palgrave Macmillan.
Constitutional Law,criminal procedure,Death Penalty,First Amendment,Habeas Corpus,Religious Liberty,sex discriminiation,Supreme Court
My research mainly focuses on constitutional law issues, including the First Amendment and social media, same-sex marriage/divorce, criminal procedure and, most recently, the Justices themselves. I was fortunate to work with two federal judges, the Honorable Jerry Buchmeyer (a legal legend in the Dallas area) and the Honorable Jane J. Boyle. These two individuals taught me not only the importance of law but also the vital nature of justice.
Affordable Housing,California Wildfires,ecological economics,Economics,economy and the environment,Environmental Protection
Dr. Reksten joined the economics department at the University of Redlands in 2016 after teaching at Sarah Lawrence College and American University. His expertise ranges from basic economics to the economic impact of environmental issues. He is an award-winning educator and researcher with a unique focus on economics and the environment.
Lina Begdache, PhD
Assistant Professor of Health and Wellness Studies
Binghamton University, State University of New YorkFood,Mental Distress,Microbiota,Neurodegeneration,Nutrigenomics,Nutrition
Lina Begdache, assistant professor of health and wellness studies at Binghamton University, has been featured by publications such as Bustle, The New York Post, Newsweek and more for her research around food and mood/stress. Her research interests include nutrigenomics and nutrigenetics, neurodegeneration, nutrition and mental distress, and microbiota.
Marjorie Speers, Ph.D Yale University, Psychology and medical epidemiology
Executive Director - Clinical Research Pathways
Clinical Research Pathwaysclinical trial,Clinical Research,Clinical Trials,Compassionate Care,Expanded Access,Expanded Access Program,FDA,Human Research Protection Programs,IRB,IRBS,Research Ethics
Marjorie A. Speers, Ph.D., is a global leader in human research protections. Most recently, she was the inaugural president and CEO of the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), retiring in 2013. Dr. Speers views the opportunity to lead this one-of-a-kind foundation—and continue to contribute to research protections and public well-being worldwide—as the natural progression in an exemplary career of public service. Before establishing AAHRPP in 2001, she served as acting executive director of the National Bioethics Advisory Commission. At the Centers for Disease Control and Prevention, she oversaw research protections for all domestic and international research. Dr. Speers is a graduate of Dickinson College, where she serves on the Board of Trustees and established a scholarship that has benefited numerous international students. She also holds doctoral degrees in psychology and epidemiology from Yale University.
Health system leadership,Healthcare,hospital administration,Medicine
Practicing internal medicine physician who has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also chair of the National Patient Safety Foundation Lucian Leape Institute and immediate past chair of the Institute for Healthcare Improvement Board of Directors. During his tenure as chief executive, Virginia Mason has become a national leader in quality, safety and innovation resulting from its Toyota Production System-inspired lean management methodology, the Virginia Mason Production System. To schedule an interview with Dr. Kaplan, contact Virginia Mason Media Relations.
Breast Cancer,Cancer,intraoperative radiotherapy,Research,Womens Health
Neil B. Friedman, M.D., FACS, is Director of The Hoffberger Breast Center at Mercy as well as Medical Director of The Weinberg Center for Women's Health and Medicine at Mercy. As a catalyst for advancing breast cancer treatment, Dr. Friedman has partnered with many prestigious national and local organizations to improve the treatment options for women with breast cancer. Likewise, on a very personal level, he partners with each of his patients and their families to help them face the challenges and triumphs of living with a breast cancer diagnosis. Dr. Friedman led the charge to bring IORT, Intraoperative Radiotherapy, to Mercy making it the first hospital in Maryland to offer this leading-edge technology. Dr. Friedmane began his medical career as Chief Resident at the nationally renowned Memorial Sloan-Kettering Cancer Center in New York. He is a Board Certified breast cancer doctor who is dedicated to the search for a cure for cancer. His team continues to lead breast cancer initiatives and introduce best-in-practice breast care treatment options, including Intraoperative Radiotherapy (IORT), an innovative, single-dose radiation treatment, to patients. Dr. Friedman was named Humanitarian of the Year by the Mildred Mindell Cancer Foundation for his efforts in the fight against breast cancer. He has served as a national spokesperson for breast cancer prevention for major organizations such as Bath & Bodyworks. Dr. Friedman has been the Chairman of the American Cancer Society’s Research Administrative Committee, a member of its Executive and Professional Education Committees, and served on its Board of Directors. He has also been involved with the Susan G. Komen Breast Cancer Foundation. Dr. Friedman leads a team of clinicians devoted to breast cancer education, advocating the latest advancements in diagnosis and treatment of breast cancer at a number of conferences, continuing education forums, and patient seminars. Dr. Neil Friedman remains committed in his career to find optimal treatments for breast cancer. Some of his accomplishments include: • Named a “Top Doc” by Baltimore magazine in the Breast Surgery category • Named Humanitarian of the Year by the Mildred Mindell Cancer Foundation • The Breast Center at Mercy Medical Center first in Maryland to offer IORT Treatment • Research on cancer has been published in American Journal of Public Health(APHA) and the Journal of Immunotherapy
Armando Sardi, MD, FACS
Medical Director, The Institute for Cancer Care at Mercy Chief, Division of Surgical Oncology
Mercy Medical CenterCancer,Hyperthermic Intraperitoneal Chemotherapy,medical director,Oncologist,Thyroid Cancer
Armando Sardi, M.D., is a respected and renowned Surgical Oncologist who has been honored as a Top Doc in Baltimore magazine multiple times. He serves as Medical Director of The Institute for Cancer Care at Mercy and as Chief of Division of Surgical Oncology at Mercy Medical Center in Downtown Baltimore, Maryland. Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late-stage, complex cancers of the abdominal region. Dr. Sardi has been performing HIPEC procedures since 1994 and is considered to be among the best doctors using the technique. This advanced heated chemotherapy procedure is often a life-saving treatment option for patients who have exhausted more traditional treatment plans for stomach cancer. Patients have traveled to Mercy Medical Center from points up and down the East Coast to destinations across the U.S., to seek out Dr. Sardi for his cancer expertise in the HIPEC treatment. Dr. Armando Sardi is a man whose professional focus is devoted to medical excellence, research and finding a cure for cancer. For his patients, Dr. Sardi’s personal concern and approach to their care are what helps them gain a positive outlook and confidence to face the challenges ahead. His cheerful smile and kind-hearted laugh immediately put patients at ease. And yet, his unyielding determination to give every patient the best possible chance to overcome their illness that ranks him among the best of the best. When other doctors have told patients there is no hope, Dr. Sardi tries even harder to beat the odds. Thanks to Dr. Sardi, the HIPEC procedure and other leading-edge treatment options, he has given patients so much more than hope. Patient after patient, year after year, have shared their stories at Mercy’s National Cancer Day Survivor Celebration and Mercy's annual Heat It to Beat It fundraising event. There are 3, 5, 10-year cancer survivors – each telling a heartwarming story of hope and survivorship. Dr. Sardi co-chair Mercy’s Cancer Committee and actively participates in The Tumor Board. These efforts allow cancer experts, specialists and key members of the healthcare team to discuss and collaborate on complex cancer cases to learn new and different ways to optimize resources, medical knowledge and treat patients so that long-term results will be improved. Dr. Sardi also plays a key role in the Mercy National Cancer Survivor Day festivities. This joyous and spirited celebration is more than a reunion of cancer survivors, it is a day when Dr. Sardi and the Mercy family rejoice with their patients and loved ones. Together they have been through a long and challenging cancer journey and together they delight in all the possibilities ahead. Dr. Armando Sardi, whose celebrated reputation has garnered local and international acclaim, has earned an international reputation for the advances he has made in the surgical oncology field and for his humanitarian efforts to care for the poor and underserved in third world countries. Dr. Sardi has been distinguished in Colombia, South America as one of the 100 Most Influential Expatriates – an honor received, in part, for the medical care he provides through the non-profit organization, Partners for Cancer Care and Prevention. This organization was the recipient of the Conquer Cancer Foundation's Inaugural International Innovation Grant. Dr. Armando Sardi has been recognized for his research, leadership and compassionate bedside manner. Some of his awards include: “Hispanic Hero Award for Excellence as a Medical/Social Entrepreneur” Presented by USHYEE “Gold Star Teamwork Award” Presented by The Sisters of Mercy in recognition of Gold Star performance Honored by Fusionarte as one of “100 Colombianos” who represent the talent, creativity, and perseverance of Colombia. Bogota, Colombia December 2012 Named by Baltimore Magazine a "Top Doctor" in the Surgical Oncology specialty Named by Castle Connelly Medical Ltd. a "Top Doctor" in Surgery Dr. Sardi founded the annual HEAT IT TO BEAT IT benefit walk in Baltimore to raise awareness about HIPEC and cancer treatment.
Asthma,Breastfeeding,childrens health,flu,Healthcare,Pediatric,Pediatrician,Vaccination,Water Safety
Jean S. Moorjani, MD, FAAP, is a board-certified pediatrician at Arnold Palmer Hospital for Children. She is a member of the medical education faculty that works with the pediatric residency training program. Her areas of focus include breastfeeding, asthma and children with special healthcare needs. Dr. Moorjani earned her medical degree from Virginia Commonwealth University School of Medicine in Richmond, Virginia. Dr. Moorjani is a fellow of the American Academy of Pediatrics (AAP). Within the AAP, she is a fellow of the Section on Breastfeeding, the Section on Hospital Medicine and a fellow of the Council on Communications and Media.
Birth,Birth Control,c-section,Gynecology,Labor And Delivery,OB-GYN,Obstetrics,Obstetrics & Gynecology,Prenatal,Women's Health
Christine Greves, MD, is board certified in Obstetrics and Gynecology and a fellow of the American Association of Obstetrics and Gynecology (ACOG). She received her medical degree from the University of South Florida College of Medicine where she also completed her residency. At Orlando Health's Center of Obstetrics and Gynecology, Dr. Greves provides comprehensive obstetrical and gynecological care to patients and serves as an obstetrical and gynecological surgeon at Winnie Palmer Hospital for Women & Babies. Dr. Greves is an advocate of minimally invasive surgery to reduce perioperative pain and speed up recovery time. One of her many passions encompasses women’s health, whether it is preventative care, health and fitness, pain, bleeding irregularities, pregnancy or any other concerns that affect a woman’s health.
Laxmi Mehta, MD
Director, Preventative Cardiology and Women's Hear
Ohio State University Wexner Medical CenterCardiac Imaging,Cardiac Rehabilitation,Cardiovascular Disease,preventative cardiology,Women's Heart Disease,Women's Heart Health
Laxmi Mehta, M.D., FACC, FAHA is the Director of the Women’s Cardiovascular Health Program and an Associate Professor of Medicine at The Ohio State University Wexner Medical Center. Dr. Mehta is also the Associate Program Director for Education for Ohio State’s Center for Women’s Health. She is the President of the Ohio Chapter of the American College of Cardiology and has previously served two terms as Secretary/Treasurer for the Ohio-ACC Chapter. Additionally, she is the Immediate Past President of the metro Columbus Board of Directors for the American Heart Association and now currently serves on the Great Rivers Affiliate Board for the American Heart Association. She sits on several national committees for both the American College of Cardiology and the American Heart Association. Dr. Mehta was chosen by Business First Magazine as one of Columbus' Top 40 under 40 in 2010 and honored as one of 12 women for the 2012 Women for Economic Leadership (WELD) Women You Should Know Calendar Honoree. She specializes in women’s cardiovascular health, prevention and cardiac imaging. Dr. Mehta is an avid promoter and educator on women’s cardiovascular health and has published a number of peer-reviewed articles and book chapters. She is a Fellow of the American College of Cardiology and the American Heart Association. She received her M.D. degree from Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown, Ohio in 1998. She completed her Internal Medicine residency training and Clinical Cardiology fellowship training at William Beaumont Hospital in Royal Oak, Michigan in 2001 and 2005.
Please enter your username and
password to login
close
-
News keyboard_arrow_right
Latest News Coronavirus News Currently Embargoed News Research News Releases Google Fact Check Research Alert Preprints Marketplace News with Video/Audio
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right